BALDANTI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 6.582
EU - Europa 5.631
AS - Asia 3.456
SA - Sud America 444
AF - Africa 46
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 16.181
Nazione #
US - Stati Uniti d'America 6.498
CN - Cina 2.323
IE - Irlanda 1.547
RU - Federazione Russa 1.113
IT - Italia 703
SG - Singapore 674
DE - Germania 506
FI - Finlandia 504
UA - Ucraina 404
BR - Brasile 401
SE - Svezia 258
GB - Regno Unito 233
HK - Hong Kong 210
FR - Francia 134
IN - India 60
CA - Canada 56
NL - Olanda 47
BE - Belgio 42
JP - Giappone 41
AT - Austria 35
IR - Iran 19
MA - Marocco 18
RO - Romania 18
TR - Turchia 17
AR - Argentina 16
AU - Australia 15
CZ - Repubblica Ceca 14
MX - Messico 13
MU - Mauritius 11
CH - Svizzera 10
AZ - Azerbaigian 9
GR - Grecia 9
IQ - Iraq 9
JM - Giamaica 8
LV - Lettonia 8
PK - Pakistan 8
VN - Vietnam 8
EC - Ecuador 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
ES - Italia 6
LT - Lituania 6
EG - Egitto 5
LK - Sri Lanka 5
PE - Perù 5
PH - Filippine 5
ZA - Sudafrica 5
AM - Armenia 4
CL - Cile 4
CO - Colombia 4
EE - Estonia 4
EU - Europa 4
GE - Georgia 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
DZ - Algeria 3
HU - Ungheria 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
PA - Panama 3
QA - Qatar 3
TH - Thailandia 3
TW - Taiwan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
GT - Guatemala 2
KE - Kenya 2
KR - Corea 2
LU - Lussemburgo 2
MD - Moldavia 2
OM - Oman 2
SI - Slovenia 2
TJ - Tagikistan 2
AL - Albania 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
ID - Indonesia 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 16.181
Città #
Dublin 1.526
Chandler 1.314
Ashburn 583
Jacksonville 571
Nanjing 503
Boardman 492
Singapore 365
Helsinki 313
Princeton 288
Wilmington 280
Lawrence 257
Beijing 247
Shanghai 235
Nanchang 230
New York 215
Moscow 214
Hong Kong 207
Medford 188
Hebei 183
Shenyang 172
Changsha 152
Milan 149
Jiaxing 140
Pavia 132
Ann Arbor 123
Hangzhou 105
Los Angeles 92
Tianjin 89
Woodbridge 82
Seattle 80
Houston 61
Fairfield 56
Falkenstein 48
Nuremberg 46
Pune 46
Toronto 45
Washington 43
Frankfurt am Main 42
Norwalk 41
Brussels 39
Düsseldorf 36
Munich 33
Tokyo 30
Rome 29
São Paulo 28
Falls Church 26
London 21
Dallas 19
Verona 19
Piscataway 18
Zhengzhou 18
San Francisco 17
Belo Horizonte 16
Jinan 16
Ningbo 15
Guangzhou 14
Paris 14
Chicago 13
Redwood City 13
Vienna 13
Auburn Hills 12
Lauterbourg 12
Taizhou 12
The Dalles 11
Turin 11
Vicenza 11
Rivoli 10
Timisoara 10
Baku 9
Brno 9
Florence 9
Zanjan 9
Brescia 8
Kunming 8
Lecce 8
Porto Alegre 8
Portsmouth 8
Rio de Janeiro 8
Tappahannock 8
Amsterdam 7
Berlin 7
Borås 7
Cambridge 7
Ribeirão Preto 7
Xi'an 7
Buenos Aires 6
Des Moines 6
Genoa 6
Melbourne 6
Montes Claros 6
Naples 6
Taranto 6
Cairo 5
Campo Grande 5
Chiavari 5
Colombo 5
Como 5
Newark 5
Orange 5
Rabat 5
Totale 10.707
Nome #
Adoptive transfer of herpesvirus-specific cytotoxic T lymphocytes in transplant recipients 107
Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates. 91
T-lymphocytes with high proliferative capacity correlate with control of viral suppression in chronically untreated HIV-1 infected individual 90
Postinfectious neurologic syndromes: A prospective cohort study 90
Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing. 90
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. 87
Compartmentalized replication of sars-cov-2 in upper vs. Lower respiratory tract assessed by whole genome quasispecies analysis 87
Diagnosis and counseling of fetal and neonatal HCMV infection. 85
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 85
A new Real-Time RT-PCR Assay for Detection of Human Enterovirus 68 (EV-D68) in Respiratory Samples. 84
Accumulation of defective HIV-1 variants in a patient with slow disease progression. 83
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 82
Herpes virus-6 chromosomal integration misled the management of Crohn’s disease 81
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 79
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 77
A novel human enterovirus C (EV-C118) identified in two children hospitalised because of acute otitis media and community-acquired pneumonia in Israel. 77
Human enterovirus and parechovirus infections in newborns with sepsis-like illness and neurological disorders. 77
Persistent human cosavirus infection in lung transplant recipient, Italy. 77
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 76
Viral outbreaks in neonatal intensive care units: what we do not know. 76
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 74
Phylogenetic analysis of HIV type 1 CRF02_AG in multiple genes in Italian and African patients living in Italy. 73
Comparison of three different methods for the evaluation of IL28 and ITPA polymorphisms in patients infected with HCV. 73
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 73
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 73
Colitis in an elderly immunocompetent patient. 73
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 73
Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19 73
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. 72
Imported hantavirus cardiopulmonary syndrome in an Italian traveller returning from Cuba. 71
Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients. 71
Epstein-Barr Virus positive aggressive lymphoma as a consequence of immunosuppression after multiple salvage treatments for follicular lymphoma. 70
Acute cytomegalovirus infection as a cause of venous thromboembolism. 70
Segregation of virulent influenza A(H1N1) variants in the lower respiratory tract of critically ill patients during the 2010-2011 seasonal epidemic 70
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 70
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 70
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 69
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. 69
Usutu Virus Antibodies in Blood Donors and Healthy Forestry Workers in the Lombardy Region, Northern Italy 69
Occult HIV infection in a large sample of health-care users in Lombardy, Italy in 2014-2015: Implications for control strategies 69
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 69
Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients. 68
Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. 68
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients 68
Maternal, fetal, and neonatal parameters for prognosis and counseling of HCMV congenital infection. 68
Emerging and re-emerging virus infections in neonates and young pediatric patients. 68
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 68
Enterovirus-D68 (EV-D68) in pediatric patients with respiratory infection: The circulation of a new B3 clade in Italy 68
Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function from T cells of EBV-seronegative children 67
Virtual quantification of influenza A virus load by real-time RT-PCR. 67
Genome characterisation of enteroviruses 117 and 118: a new group within human enterovirus species C. 67
Complete genome characterization of enterovirus 104 circulating in Northern Italy shows recombinant origin of the P3 region. 67
Surveillance and vaccination coverage of measles and rubella in Northern Italy. 66
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients. 66
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. 66
Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemtive therapy in bone marrow transplant recipients 66
Possible role of viral reactivations in the lack of response to conventional therapies in patients with inflammatory bowel disease (IBS) 66
HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. 66
Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. 66
Frequency of respiratory virus infections and next-generation analysis of influenza A/ H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU 66
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 66
Expanding usutu virus circulation in italy: Detection in the Lazio region, central Italy, 2017 to 2018 66
Letter to the editor. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. 65
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. 65
Novel human enterovirus C infection in child with community-acquired Pneumonia. 65
Circulation of two Enterovirus C105 (EV-C105) lineages in Europe and Africa. 65
Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease 65
The pentameric complex of human cytomegalovirus: Cell tropism, virus dissemination, immune response and vaccine development 65
12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 65
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 65
Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. 64
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis. 64
Severe outcome of influenza A/H1N1/09v infection associated with 222G/N polymorphisms in the haemagglutinin: a multicenter study. 64
Xenotropic and polytropic murine leukemia virus-related sequences are not detected in the majority of patients with chronic fatigue syndrome. 64
Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency 64
Reconstruction of the evolutionary dynamics of the A(H1N1)pdm09 influenza virus in Italy during the pandemic and post-pandemic phases. 64
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. 64
Authors’ reply: Two severe human cases due to swine influenza a (H1N1)v in October 2016 in Europe were chronologic coincident yet distinct events 64
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 64
Successful medical treatment of EBV smooth muscle tumor in a renal transplant recipient. 63
Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection. 63
Zika virus isolation from semen 63
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 63
Vaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM). 62
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. 62
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 62
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 62
Nevirapine-selected mutations Y1811/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine 61
Comparison of immunologic and molecular assays for the diagnosis of gastrointestinal viral infections. 61
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 61
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group. 60
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study 60
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 60
Multiple clusters of A(H1N1)pdm09 virus circulating in severe cases of influenza during the 2010-2011 season: a phylogenetic and molecular analysis of the neuraminidase gene. 59
Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linted immunospot assay. 59
Contribution of Enteroviruses to Acute Central Nervous System or Systemic Infections in Northern Italy (2015-2017): Is It Time to Establish a National Laboratory-Based Surveillance System? 59
Diagnosing acute encephalitis in patients with hematological disorders: caveats and pitfalls 59
T cell therapy of Epstein-Barr virus and adenovirus infections after hemopoietic stem cell transplant 58
Complete genome sequence of a novel human enterovirus C (HEV-C117) identified in a child with community-acquired pneumonia. 58
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection 58
Totale 6.948
Categoria #
all - tutte 96.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020324 0 0 0 0 0 0 0 0 0 171 148 5
2020/20211.122 94 81 96 72 10 120 52 228 77 145 107 40
2021/20221.251 23 14 27 46 52 29 33 65 72 42 179 669
2022/20234.066 405 278 77 280 328 348 6 203 1.820 41 205 75
2023/20242.446 278 396 101 128 252 594 184 159 29 100 106 119
2024/20254.251 163 452 141 215 112 391 372 382 1.658 365 0 0
Totale 16.797